ImmunityBio, Inc. (IBRX)
2.205
-0.02
(-0.68%)
USD |
NASDAQ |
Dec 10, 14:36
ImmunityBio EPS Diluted (Quarterly): -0.071 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Hims & Hers Health, Inc. | 0.0634 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Anixa Biosciences, Inc. | -0.0695 |
| Iovance Biotherapeutics, Inc. | -0.2507 |
| Summit Therapeutics, Inc. | -0.3118 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -67.27M |
| Revenue (Quarterly) | 32.06M |
| Total Expenses (Quarterly) | 99.31M |
| Enterprise Value | 2.791B |
| Gross Profit Margin (Quarterly) | 87.12% |
| Profit Margin (Quarterly) | -209.8% |
| Earnings Yield | -19.07% |
| Normalized Earnings Yield | -20.40 |